Aariva Pharma Private Limited, a active private limited company, was established on 21 August 2010 in Savli, Gujarat, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24230GJ2010PTC062056. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Gaurang Rajnikant Shah (Director), Rakeshkumar Shankarlal Shah (Additional Director), Amisha R Shah (Additional Director). Past directors included Dhaval Atulkumar Shah, Rituben Atulkumar Shah, Amisha R Shah. It holds ₹7.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No. 809,, Mevli Road, Samlaya, Savli, Gujarat, 391520.
U24230GJ2010PTC062056
062056
21 August 2010
₹1.50 M
₹1.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Aariva Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurang Rajnikant Shah | Director | 07 Sep 2012 | Current |
| Rakeshkumar Shankarlal Shah | Additional Director | 24 Dec 2018 | Current |
| Amisha R Shah | Additional Director | 07 Nov 2014 | Current |
| Jyotika Gaurang Shah | Director | 21 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Dec 2018 | Past |
| Pramod Abcsdd | Director | 16 Feb 2013 | Past |
| Pramod Abcsdd | Director | 16 Feb 2013 | Past |
| Pramod Abcsdd | Director | 24 Dec 2018 | Past |
| Pramod Abcsdd | Director | 23 Mar 2024 | Past |
| Pramod Abcsdd | Director | 27 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aariva Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.16% decrease. The company also saw a substantial fall in profitability, with a 20.83% decrease in profit. The company's net worth moved up by a moderate rise of 5.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aariva Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹70,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2020 | Others | ₹5.00 Cr | Open |
| 06 Feb 2015 | Fedral Bank | ₹1.00 Cr | Open |
| 29 Jan 2015 | Fedral Bank | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aariva Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aariva Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aariva Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aariva Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Aariva Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
A charge with Others of Rs. 50.00 M registered on 16 Jun 2020 with Charge ID 100346343 was modified on 27 Mar 2024. was recorded as a recent event.
Progress on Jyotika Gaurang Shah was appointed as a Director was appointed as a Director on 21 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity A charge with Others amounted to Rs. 50.00 M with Charge ID 100346343 was registered on 16 Jun 2020. was completed.
Progress on Rakeshkumar Shankarlal Shah was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2018 & has been associated with this company since 6 years 11 months . was documented.
The CIN of Aariva Pharma Private Limited is U24230GJ2010PTC062056.
Aariva Pharma Private Limited is headquartered at Survey No. 809,, Mevli Road, Samlaya, Savli, Gujarat, 391520.
Aariva Pharma Private Limited was incorporated on 21 August 2010.
The current directors of Aariva Pharma Private Limited are
The primary industry of Aariva Pharma Private Limited is Manufacturing.
Aariva Pharma Private Limited is unlisted.
The authorized capital of Aariva Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Aariva Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX